Your browser doesn't support javascript.
loading
ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.
Powles, T; Bellmunt, J; Comperat, E; De Santis, M; Huddart, R; Loriot, Y; Necchi, A; Valderrama, B P; Ravaud, A; Shariat, S F; Szabados, B; van der Heijden, M S; Gillessen, S.
Afiliación
  • Powles T; Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, UK.
  • Bellmunt J; Department of Hematology and Oncology, Dana-Farber Cancer Institute, Harvard Cancer Centre, Boston, USA.
  • Comperat E; Department of Pathology, Medical University Vienna, Austria.
  • De Santis M; Department of Urology, Charité Universitätsmedizin, Berlin, Germany; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Huddart R; Royal Marsden Hospital, Institute of Cancer Research, London, UK.
  • Loriot Y; Department of Medical Oncology, Université Paris-Saclay and Gustave Roussy, Villejuif, France.
  • Necchi A; Vita-Salute San Raffaele University, Milan; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Valderrama BP; Department of Medical Oncology, University Hospital Virgen del Rocio, Seville, Spain.
  • Ravaud A; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York; Department of Urology, University of Texas Southwestern, Dallas, USA; Division of Urology, Department of Special Surgery, University of J
  • Szabados B; Barts Cancer Centre, Barts Health NHS Trust, Queen Mary University of London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
  • van der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Gillessen S; Oncology Institute of Southern Switzerland (EOC-IOSI), Bellinzona; Università della Svizzera italiana (USI), Lugano, Switzerland.
Ann Oncol ; 35(6): 485-490, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38490358
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article